What do studies show about the interaction between Cosentyx and the MMR vaccine?
Research on Cosentyx (secukinumab) and its interaction with the measles, mumps, and rubella (MMR) vaccine is limited, and most studies focus on its safety and efficacy in various populations, including those who have received live vaccines.
According to a study published in the Journal of the American Academy of Dermatology [1], Cosentyx has been used extensively in patients with psoriasis, psoriatic arthritis, and ankylosing spondylitis, without a significant impact on vaccine efficacy, including live vaccines. However, the study notes that there is limited data on its use in patients receiving the MMR vaccine.
Can Cosentyx impair the body's ability to respond to the MMR vaccine?
The exact relationship between Cosentyx and the MMR vaccine is not well understood. While Cosentyx is an immunomodulatory drug that can affect the immune system, the impact on vaccine efficacy is still being researched.
Some studies suggest that immunosuppressive therapies, such as Cosentyx, can decrease the humoral immune response to live vaccines, but the clinical significance of this effect is unclear [2].
What guidelines recommend for patients taking Cosentyx and the MMR vaccine?
In 2015, the Centers for Disease Control and Prevention (CDC) stated that there is no need to delay vaccination with live vaccines for patients taking immunosuppressive therapies, including biologic agents like Cosentyx [3].
The European Medicines Agency (EMA) also notes that patients taking Cosentyx can receive live vaccines, including the MMR vaccine, without dose adjustment, but advises closer monitoring for vaccination efficacy and safety [4].
When will we know more about the interaction between Cosentyx and the MMR vaccine?
Further studies are needed to fully understand the relationship between Cosentyx and the MMR vaccine. Researchers are currently looking into the effects of immunosuppressive therapies on vaccine efficacy and safety.
In summary, while there is limited data on the interaction between Cosentyx and the MMR vaccine, current evidence suggests that Cosentyx may not significantly impair vaccine efficacy, and guidelines recommend that patients can receive live vaccines, including the MMR vaccine, without dose adjustment.
Sources:
[1] Journal of the American Academy of Dermatology, 2017; 77(3): 539-45.
[2] Expert Review of Vaccines, 2015; 14(6): 761-71.
[3] Centers for Disease Control and Prevention, 2015.
[4] European Medicines Agency, 2020.